MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 234 filers reported holding MYRIAD GENETICS INC in Q1 2016. The put-call ratio across all filers is 2.27 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $402,000 | -88.7% | 13,616 | -86.8% | 0.06% | -86.9% |
| Q4 2017 | $3,545,000 | -12.2% | 103,216 | -7.5% | 0.43% | -3.4% |
| Q3 2017 | $4,036,000 | +37.4% | 111,561 | -1.8% | 0.44% | +23.5% |
| Q2 2017 | $2,937,000 | +57.3% | 113,661 | +16.9% | 0.36% | +55.2% |
| Q1 2017 | $1,867,000 | +99.7% | 97,261 | +73.5% | 0.23% | +38.6% |
| Q4 2016 | $935,000 | +31.5% | 56,061 | +62.2% | 0.17% | -0.6% |
| Q3 2016 | $711,000 | +103.1% | 34,561 | +201.8% | 0.17% | +89.8% |
| Q2 2016 | $350,000 | +1.7% | 11,450 | +24.5% | 0.09% | -20.7% |
| Q1 2016 | $344,000 | – | 9,200 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 2,750,000 | $75,900,000 | 2.61% |
| PFM Health Sciences, LP | 2,025,681 | $55,909,000 | 1.90% |
| Tieton Capital Management, LLC | 118,456 | $3,269,000 | 1.83% |
| Altium Capital Management LP | 190,000 | $5,244,000 | 1.45% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 1,846,490 | $50,963,000 | 1.03% |
| EARNEST PARTNERS LLC | 6,316,365 | $174,332,000 | 1.01% |
| Glenview Capital Management | 1,679,747 | $46,361,000 | 0.99% |
| Zebra Capital Management LLC | 14,209 | $392,000 | 0.63% |
| AIMZ Investment Advisors, LLC | 44,185 | $1,220,000 | 0.48% |
| Phocas Financial Corp. | 132,101 | $3,646,000 | 0.46% |